Multi-photon microscope for the Indiana Center for Biological Microscopy

印第安纳生物显微镜中心的多光子显微镜

基本信息

项目摘要

DESCRIPTION (provided by applicant): This request is for funds to purchase an Olympus Fluoview 1000MPE confocal/multiphoton fluorescence microscope system. This instrument will be housed, managed and maintained by the Indiana Center for Biological Microscopy (ICBM), a core facility of the Indiana University School of Medicine and the Indiana University George M. O'Brien Center for Advanced Renal Microscopic Analysis. Confocal and multiphoton microscopy are essential services of the center, which operates four confocal microscopes, two of which are equipped for multiphoton fluorescence microscopy. An eleven-year old BioRad MRC1024MP system accounts for a major fraction of current microscope utilization, but, due to its age, will soon lose service contract support. We seek to replace this dated and increasingly unreliable system with a new Olympus Fluoview system. Replacing the BioRad system with a new Olympus system will, 1. Provide users with a reliable instrument that will be supported by an ongoing manufacturer's service agreement, 2. Provide users with a modern system with enhanced performance and capabilities. The requested system is absolutely essential to the ICBM, which supports the research of over 68 NIH- funded laboratories, and is particularly crucial to the group of major users listed in this proposal, whose research has come to depend upon the current BioRad system. In addition to supporting Indiana University researchers, this system is also the primary microscope of our NIH-funded O'Brien Center, supporting the research of renal investigators throughout the world. The loss of this system will profoundly compromise the ability of the ICBM to function as a university core facility, and as a center of renal microscopy. Acquiring the new Olympus system will ensure the continued productive use of confocal/multiphoton microscopy at the ICBM Relevance - The proposed instrument is a crucial tool in the research of numerous biomedical investigators studying the cellular basis of disease. In particular, studies of living animals conducted with this instrument are uniquely powerful for elucidating disease processes and therapies in the context of the whole organism, making them better predictors of clinical outcomes.
描述(由申请人提供):本申请旨在获得购买Olympus Fluoview 1000 MPE共焦/多光子荧光显微镜系统的资金。该仪器将由印第安纳州生物显微镜中心(ICBM)存放、管理和维护,ICBM是印第安纳州大学医学院和印第安纳州大学乔治M。奥布莱恩高级肾脏显微镜分析中心。共聚焦和多光子显微镜是该中心的基本服务,该中心拥有四台共聚焦显微镜,其中两台配备了多光子荧光显微镜。已有11年历史的BioRad MRC 1024 MP系统占当前显微镜使用的主要部分,但由于其年龄,将很快失去服务合同支持。我们试图用新的Olympus Fluoview系统替换这一过时且越来越不可靠的系统。用新的Olympus系统替换BioRad系统将:1.为用户提供一个可靠的仪器,将支持一个正在进行的制造商的服务协议,2.为用户提供具有增强性能和功能的现代化系统。所要求的系统对洲际弹道导弹来说绝对是必不可少的,因为洲际弹道导弹支持着超过68个由国家卫生研究院资助的实验室的研究,而且对本提案中所列的主要用户群体来说尤其重要,因为他们的研究已经依赖于目前的BioRad系统。除了支持印第安纳州大学的研究人员外,该系统也是我们NIH资助的奥布莱恩中心的主要显微镜,支持世界各地肾脏研究人员的研究。这个系统的损失将严重损害洲际弹道导弹作为大学核心设施和肾脏显微镜中心的能力。获得新的奥林巴斯系统将确保在洲际弹道导弹上继续有效地使用共聚焦/多光子显微镜-拟议的仪器是许多生物医学研究人员研究疾病细胞基础的重要工具。特别是,使用该仪器进行的活体动物研究对于阐明整个生物体背景下的疾病过程和治疗具有独特的功能,使其成为临床结果的更好预测者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KENNETH W DUNN其他文献

KENNETH W DUNN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KENNETH W DUNN', 18)}}的其他基金

Intravital Microscopy Biomedical Resource Core
活体显微镜生物医学资源核心
  • 批准号:
    10747618
  • 财政年份:
    2023
  • 资助金额:
    $ 49.92万
  • 项目类别:
Resource Development Core
资源开发核心
  • 批准号:
    10747620
  • 财政年份:
    2023
  • 资助金额:
    $ 49.92万
  • 项目类别:
Microscopy Core
显微镜核心
  • 批准号:
    10427466
  • 财政年份:
    2015
  • 资助金额:
    $ 49.92万
  • 项目类别:
Microscopy Core
显微镜核心
  • 批准号:
    10155471
  • 财政年份:
    2015
  • 资助金额:
    $ 49.92万
  • 项目类别:
Development of a Multiscale Mechanistic Simulation of Acetaminophen Induced Liver
对乙酰氨基酚诱导肝脏的多尺度机制模拟的开发
  • 批准号:
    8743591
  • 财政年份:
    2014
  • 资助金额:
    $ 49.92万
  • 项目类别:
Kidney Multiphoton Analysis of Therapeutic Agents
治疗药物的肾脏多光子分析
  • 批准号:
    7218512
  • 财政年份:
    2007
  • 资助金额:
    $ 49.92万
  • 项目类别:
Kidney Multiphoton Analysis of Therapeutic Agents
治疗药物的肾脏多光子分析
  • 批准号:
    7806134
  • 财政年份:
    2007
  • 资助金额:
    $ 49.92万
  • 项目类别:
Kidney Multiphoton Analysis of Therapeutic Agents
治疗药物的肾脏多光子分析
  • 批准号:
    8120810
  • 财政年份:
    2007
  • 资助金额:
    $ 49.92万
  • 项目类别:
Core--Biological Microscopy
核心--生物显微镜
  • 批准号:
    6997996
  • 财政年份:
    2004
  • 资助金额:
    $ 49.92万
  • 项目类别:
Core--3D imaging
核心--3D成像
  • 批准号:
    6564363
  • 财政年份:
    2002
  • 资助金额:
    $ 49.92万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 49.92万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 49.92万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 49.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 49.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 49.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 49.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 49.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 49.92万
  • 项目类别:
    Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 49.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 49.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了